Edwin Bremer - Concepedia

Author

Edwin Bremer

University Medical Center Groningen ORCID

Also Known As

Bremer, E., Bremer, Edwin, E Bremer, E. Bremer, Edwin Bremer

184

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen University of Exeter Harbin Medical University Friedrich-Alexander-Universität Erlangen-Nürnberg

About

Edwin Bremer is an author at University Medical Center Groningen specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	930
2	Engineering	1	1	21
3	Natural Sciences	1	1	23
4	Allergy	1	1	37
5	Biochemistry	1	1	23

Edwin Bremer

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial Shuhong Wang, Yusheng Lin, Xiao Xiong, Clinical Cancer Research	2020	145
Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR Edwin Bremer, Douwe F. Samplonius, Linda van Genne, Journal of Biological Chemistry Signal TransductionSimultaneous InhibitionTherapeutic Apoptosis InductionSignaling PathwayReceptor Tyrosine Kinase	2005	97
Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats Yunwei Wei, Ping Chen, Marco de Bruyn, BMC Gastroenterology	2010	96
Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7 Edwin Bremer, Douwe F. Samplonius, Matthias Peipp, Cancer Research	2005	88
Target cell‐restricted and ‐enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma‐associated antigen EGP2 Edwin Bremer, Jos M.A. Kuijlen, Douwe F. Samplonius, International Journal of Cancer	2003	87
Targeting of the Tumor Necrosis Factor Receptor Superfamily for Cancer Immunotherapy Edwin Bremer ISRN Oncology Co-stimulatory Tnf LigandsApoptosisImmunologyImmune RegulationCell Death	2013	86
Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo Marco de Bruyn, Anna A. Rybczynska, Yunwei Wei, Molecular Cancer	2010	71
Frequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects Paul Eggleton, Edwin Bremer, Joanna M. Tarr, Arthritis Research & Therapy	2011	70
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination Janet E. Holley, Edwin Bremer, Alexandra C. Kendall, Multiple Sclerosis and Related Disorders Multiple Sclerosis PatientsAutoimmune DiseaseMedicineApoptotic EliminationT-regulatory Cell	2014	68
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy Fenne L. Komdeur, Maartje C.A. Wouters, Hagma H. Workel, Oncotarget Checkpoint InhibitionLymphocyte DevelopmentT-regulatory CellImmunologyImmune Regulation	2016	68

Page 1